Clinical Trial Update: Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection

View source ↗

Summary

This clinical trial update assesses the effectiveness and safety of combining dabrafenib with trametinib as adjuvant therapy for Chinese patients with stage III…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dabrafenib (Dabrafenib)
• Trametinib (trametinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Melanoma | Status: ACTIVE_NOT_RECRUITING